Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Humphries

Showing results (21-30 of 39) with videos related to

Pageof 4
Sort By:
The British Journal of Clinical Psychology|October 29, 2005
The detection of malingering in memory performance: the sensitivity and specificity of four measures in a UK populationP J Kelly, G A Baker, M D van den Broek, et al.
Prostaglandins|April 1, 1973
The effect of prostaglandin F2 antibody on gestation length in the ratM V Dunn, N G Humphries, G R Judkins, et al.
Experimental Physiology|January 1, 1990
Effective pulmonary flow, aortic flow and cardiac output: in vitro and in vivo comparisons in the dogP J Franks, R H Hooper, R G Humphries, et al.
Molecular and Cellular Biology|July 1, 1990
Immunoglobulin D switching can occur through homologous recombination in human B cellsM B White, C J Word, C G Humphries, et al.
British Journal of Pharmacology|June 16, 2001
The C6-2B glioma cell P2Y(AC) receptor is pharmacologically and molecularly identical to the platelet P2Y(12) receptorJ Jin, W Tomlinson, I P Kirk, et al.
British Journal of Pharmacology|July 1, 1995
Pharmacological profile of the novel P2T-purinoceptor antagonist, FPL 67085 in vitro and in the anaesthetized rat in vivoR G Humphries, W Tomlinson, J A Clegg, et al.
Nature|February 4, 1988
A new human immunoglobulin VH family preferentially rearranged in immature B-cell tumoursC G Humphries, A Shen, W A Kuziel, et al.
British Journal of Pharmacology|July 1, 1985
The effects of dopexamine on the cardiovascular system of the dogR A Brown, J B Farmer, J C Hall, et al.
British Journal of Pharmacology|June 18, 1998
P2Y1-receptors in human platelets which are pharmacologically distinct from P2Y(ADP)-receptorsM S Fagura, I A Dainty, G D McKay, et al.
Oncotarget|September 15, 2016
The ubiquitin ligase TRIM25 targets ERG for degradation in prostate cancerShan Wang, Rahul K Kollipara, Caroline G Humphries, et al.
Pageof 4

Showing results (21-30 of 39) with videos related to

Sort By:
Pageof 4
The British Journal of Clinical Psychology|October 29, 2005
The detection of malingering in memory performance: the sensitivity and specificity of four measures in a UK populationP J Kelly, G A Baker, M D van den Broek, et al.
Prostaglandins|April 1, 1973
The effect of prostaglandin F2 antibody on gestation length in the ratM V Dunn, N G Humphries, G R Judkins, et al.
Experimental Physiology|January 1, 1990
Effective pulmonary flow, aortic flow and cardiac output: in vitro and in vivo comparisons in the dogP J Franks, R H Hooper, R G Humphries, et al.
Molecular and Cellular Biology|July 1, 1990
Immunoglobulin D switching can occur through homologous recombination in human B cellsM B White, C J Word, C G Humphries, et al.
British Journal of Pharmacology|June 16, 2001
The C6-2B glioma cell P2Y(AC) receptor is pharmacologically and molecularly identical to the platelet P2Y(12) receptorJ Jin, W Tomlinson, I P Kirk, et al.
British Journal of Pharmacology|July 1, 1995
Pharmacological profile of the novel P2T-purinoceptor antagonist, FPL 67085 in vitro and in the anaesthetized rat in vivoR G Humphries, W Tomlinson, J A Clegg, et al.
Nature|February 4, 1988
A new human immunoglobulin VH family preferentially rearranged in immature B-cell tumoursC G Humphries, A Shen, W A Kuziel, et al.
British Journal of Pharmacology|July 1, 1985
The effects of dopexamine on the cardiovascular system of the dogR A Brown, J B Farmer, J C Hall, et al.
British Journal of Pharmacology|June 18, 1998
P2Y1-receptors in human platelets which are pharmacologically distinct from P2Y(ADP)-receptorsM S Fagura, I A Dainty, G D McKay, et al.
Oncotarget|September 15, 2016
The ubiquitin ligase TRIM25 targets ERG for degradation in prostate cancerShan Wang, Rahul K Kollipara, Caroline G Humphries, et al.
Pageof 4